UB Paderborn / Katalog / Suche / in CDI

MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer

Cancer cell, 2014-04, Vol.25 (4), p.469-483

2014

Link zum Volltext

Verfügbarkeit prüfen

Inhibitor of MYC identified in a Kröhnke pyridine library

Proceedings of the National Academy of Sciences - PNAS, 2014-08, Vol.111 (34), p.12556-12561

2014

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K)

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (47), p.16826-16829

2014

Link zum Volltext

Verfügbarkeit prüfen

butterfly effect in cancer: A single base mutation can remodel the cell

Proceedings of the National Academy of Sciences - PNAS, 2015-01, Vol.112 (4), p.1131-1136

2015

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and evaluation of a cyclic imine derivative conjugated to a fluorescent molecule for labeling of proteins

Bioorganic & medicinal chemistry letters, 2009-02, Vol.19 (4), p.1210-1213

2009

Link zum Volltext

Verfügbarkeit prüfen

Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt

International journal of cancer, 2009-12, Vol.125 (12), p.2863-2870

2009

Link zum Volltext

Verfügbarkeit prüfen

Protein expression profiles of C3H 10T1/2 murine fibroblasts and of isogenic cells transformed by the H1047R mutant of phosphoinositide 3-kinase (PI3K)

Cell cycle (Georgetown, Tex.), 2011-03, Vol.10 (6), p.971-976

2011

Link zum Volltext

Verfügbarkeit prüfen

A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling

Cell, 2016-04, Vol.165 (3), p.643-655

2016

Link zum Volltext

Verfügbarkeit prüfen

Nanobodies and chemical cross-links advance the structural and functional analysis of PI3Kα

Proceedings of the National Academy of Sciences - PNAS, 2022-09, Vol.119 (38), p.1-e2210769119

2022

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic activity of the regulatory subunit p85? of phosphatidylinositol 3-kinase (PI3K)

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (47), p.16826-16826

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3339: The regulatory subunit of PI3K, p85β, induces cellular transformation, enhanced cell proliferation and increased PI3K signaling

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3339-3339

2014

Link zum Volltext

Verfügbarkeit prüfen

Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assay

Bioorganic & medicinal chemistry, 2021-07, Vol.42, p.116246-116246, Article 116246

2021

Link zum Volltext

Verfügbarkeit prüfen

Synthetic molecules for disruption of the MYC protein-protein interface

Bioorganic & medicinal chemistry, 2018-08, Vol.26 (14), p.4234-4239

2018

Link zum Volltext

Verfügbarkeit prüfen

Akt-mediated regulation of NFkB and the essentialness of NFkB for the oncogenicity of PI3K and Akt

International journal of cancer, 2009-12, Vol.125 (12), p.2863-2870

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract B136: CAL-120, a novel dual p110β/p110δ phosphatidylinositol-3-kinase (PI3K) inhibitor, attenuates PI3K signaling and demonstrates potent in vivo antitumor activity against solid tumors

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.B136-B136

2009

Link zum Volltext

Verfügbarkeit prüfen

Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt

International journal of cancer, 2009-12, Vol.125 (12), p.2863

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4479: PF-04691502, a potent and selective PI3K/mTOR dual inhibitor with antitumor activity

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4479-4479

2010

Link zum Volltext

Verfügbarkeit prüfen

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials

Frontiers in oncology, 2022-08, Vol.12, p.963753-963753

2022

Link zum Volltext

Verfügbarkeit prüfen

Tropospheric Ozone Assessment Report: Database and metrics data of global surface ozone observations

Elementa (Washington, D.C.), 2017, Vol.5

2017

Link zum Volltext

Verfügbarkeit prüfen

Survivorship and Advocacy in Inflammatory Breast Cancer

Journal of Cancer, 2018-01, Vol.9 (8), p.1430-1436

2018

Link zum Volltext

Verfügbarkeit prüfen

Sa2021 Nausea Reported by Patients Enrolled in Clinical Studies of Lubiprostone: Analysis of Well-Controlled and Long-Term, Open-Label Studies of Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Irritable Bowel Syndrome With Constipation

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-356-S-357

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer

Inhibitor of MYC identified in a Kröhnke pyridine library

Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K)

butterfly effect in cancer: A single base mutation can remodel the cell

Synthesis and evaluation of a cyclic imine derivative conjugated to a fluorescent molecule for labeling of proteins

Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt

Protein expression profiles of C3H 10T1/2 murine fibroblasts and of isogenic cells transformed by the H1047R mutant of phosphoinositide 3-kinase (PI3K)

A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling

Nanobodies and chemical cross-links advance the structural and functional analysis of PI3Kα

Oncogenic activity of the regulatory subunit p85? of phosphatidylinositol 3-kinase (PI3K)

Abstract 3339: The regulatory subunit of PI3K, p85β, induces cellular transformation, enhanced cell proliferation and increased PI3K signaling

Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assay

Synthetic molecules for disruption of the MYC protein-protein interface

Akt-mediated regulation of NFkB and the essentialness of NFkB for the oncogenicity of PI3K and Akt

Abstract B136: CAL-120, a novel dual p110β/p110δ phosphatidylinositol-3-kinase (PI3K) inhibitor, attenuates PI3K signaling and demonstrates potent in vivo antitumor activity against solid tumors

Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt

Abstract 4479: PF-04691502, a potent and selective PI3K/mTOR dual inhibitor with antitumor activity

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials

Tropospheric Ozone Assessment Report: Database and metrics data of global surface ozone observations

Survivorship and Advocacy in Inflammatory Breast Cancer

Sa2021 Nausea Reported by Patients Enrolled in Clinical Studies of Lubiprostone: Analysis of Well-Controlled and Long-Term, Open-Label Studies of Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Irritable Bowel Syndrome With Constipation

Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study

Suchergebnisse filtern